What are the recommended dosing regimens, administration instructions, and safety considerations for bilastine in adults and children?

Bilastine Dosing and Administration

Bilastine is dosed at 20 mg once daily in adults and adolescents ≥12 years, and 10 mg once daily in children aged 2-11 years (or 6-11 years depending on regional approval), for the treatment of allergic rhinoconjunctivitis and urticaria.

Recommended Dosing Regimens

Adults and Adolescents (≥12 years)

• Standard dose: 20 mg once daily orally 1, 2
• Administered as oral tablets or orodispersible formulation
• No dose adjustment required in elderly patients 2

Pediatric Patients

• Children 6 to <12 years: 10 mg once daily (minimum body weight 20 kg) 1, 3
• Children 2 to <6 years: 10 mg once daily using orodispersible tablets 1
  • This dosing was confirmed through pharmacokinetic modeling showing linear pharmacokinetics across the 2-12 year age range 1
  • Body weight and age were not significant covariates affecting drug clearance or distribution 1

Important note: Regional approval varies—some countries approve bilastine from age 2 years (Mexico, some African countries), age 4 years (Canada), or age 6 years (Europe) 4. Verify local regulatory approval before prescribing.

Administration Instructions

Timing and Food Interactions

• Administer once daily at a consistent time
• Critical: Bilastine absorption is significantly affected by food—specific administration instructions relative to meals should be followed per local prescribing information
• The drug has rapid onset of action with peak plasma concentrations occurring approximately 1 hour after administration 1
• Long duration of action supports once-daily dosing 2

Formulations Available

• Oral tablets (20 mg for adults/adolescents)
• Orodispersible tablets (10 mg for children) 1
• Syrup formulations available in some regions 5

Safety Considerations

Excellent Safety Profile

Bilastine demonstrates minimal sedation and no anticholinergic or cardiotoxic effects 2. Key safety features include:

• Non-sedating: No central nervous system penetration, minimal sedative properties even at above-standard doses 2
• No cardiac effects: Does not prolong QT interval (unlike mizolastine) 2
• No anticholinergic effects: Unlike first-generation antihistamines 2

Drug Interactions

• Minimal interaction potential: Bilastine does not undergo significant metabolism and does not interact with the CYP450 system 2
• This is a major advantage over other antihistamines that require caution with macrolide antibiotics, imidazole antifungals, and drugs affecting cardiac conduction 6

Special Populations

Renal Impairment:

• No dose adjustment required 2
• This contrasts with cetirizine and levocetirizine, which require dose reduction in renal impairment 6

Hepatic Impairment:

• No dose adjustment required 2
• Safer than mizolastine (contraindicated in significant hepatic impairment) 6

Elderly Patients:

• No dose adjustment necessary 2
• Standard 20 mg once daily dosing applies

Pregnancy and Lactation:

• As with all antihistamines, avoid if possible, especially in first trimester 6
• No specific teratogenic effects documented, but well-controlled human studies are lacking

Pediatric Safety Data

In children aged 2-5 years treated with bilastine 10 mg daily 1:

• Only 21.6% experienced any treatment-emergent adverse event
• No severe adverse events reported
• Good tolerability profile consistent with older children and adults

Common Adverse Effects

Based on clinical trial data, bilastine is generally well tolerated with minimal side effects 1, 2. The safety profile is superior to:

• First-generation antihistamines (no sedation, urinary retention, or mucosal dryness)
• Some second-generation agents like cetirizine (which can cause sedation at higher doses) 6

Clinical Considerations

When to Use Bilastine

• First-line treatment for allergic rhinoconjunctivitis and urticaria per guideline recommendations for second-generation antihistamines 6
• Particularly suitable for patients requiring:
  • Minimal sedation (students, workers, drivers)
  • Concomitant medications (low drug interaction potential)
  • Renal or hepatic impairment (no dose adjustment needed)
  • Long-term treatment (excellent safety profile) 4

Dose Escalation

While not standard for bilastine specifically, guidelines for urticaria management note that increasing antihistamine doses above manufacturer recommendations is common practice when benefits outweigh risks 6. However, bilastine's standard dosing typically provides adequate efficacy without requiring escalation 2.

Treatment Duration

• Bilastine has been studied and used safely for long-term management of chronic spontaneous urticaria and inducible urticaria 4
• Continue treatment as needed for symptom control

Key Pitfalls to Avoid

1. Do not confuse pediatric and adult dosing: Children require 10 mg, not 20 mg
2. Verify minimum age approval in your region before prescribing to young children
3. Unlike other antihistamines, bilastine does not require dose adjustment in renal/hepatic impairment or elderly patients—do not unnecessarily reduce doses in these populations
4. Do not combine with sedating antihistamines unless specifically needed for refractory symptoms, as bilastine alone provides non-sedating efficacy